PPARG and obesity due to melanocortin 4 receptor deficiency: However, the revelation of this obesity‐specific mechanism of hepatic toxicity in our study underscores a pivotal new consideration in the pursuit of designing innovative URAT1 inhibitors derived from the structural scaffold of the necessity of ascertaining their potential PPARγ agonistic activities.